German EstSmoke: estimating adult smoking‐related costs and consequences of smoking cessation for Germany

Sonntag, Diana; Gilbody, Simon; Winkler, Volker; Ali, Shehzad

doi:10.1111/add.13956

Cited by 5 publications

(4 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Также необходимо отметить, что ужесточение антитабачной политики способствует снижению затрат на здравоохранение, что нашло отражение в результатах немецких исследователей, которые показали, что применение комплексной политики в борьбе против табака позволило сократить расходы на здравоохранение Германии для нынешних курильщиков, по крайней мере, на 4%, а отсутствие усиления политики приведет к потере 41,56 млрд евро [45].…”

Section: Discussionunclassified

Economic damage from smoking associated with four groups of chronic non-communicable diseases in the Russian Federation in 2016

Sapunova

Концевая

Мырзаматова

et al. 2019

Cardiovasc Ther Prev

View full text Add to dashboard Cite

Section: Discussionunclassified

Economic damage from smoking associated with four groups of chronic non-communicable diseases in the Russian Federation in 2016

Sapunova

Концевая

Мырзаматова

et al. 2019

Cardiovasc Ther Prev

View full text Add to dashboard Cite

“…Ten studies [141][142][143][144][145][146][147][148][149][150] were applications and/or minor extensions of the BENESCO model, 151 which was described in the previous review; 23 therefore, these studies will not be discussed in detail. Nine studies 87,89,90,104,105,[152][153][154][155] did not use a population of general smokers; therefore, they are less likely to be generalisable and may include model features that would be irrelevant in the context of general smokers. These studies are also not discussed in detail.…”

Section: Summary Of Model-based Cost-effectiveness Studies In Smoking...mentioning

confidence: 99%

“…• four studies 154,158,165,168 modelled smoking-related excess morbidity and/or mortality only • five studies 89,140,145,166,169 explicitly modelled one or more smoking-related morbidities, but did not model subsequent smoking behaviour or smoking-related excess morbidity or mortality • six studies 87,88,90,155,160,172 explicitly modelled one or more smoking-related morbidities and smokingrelated excess morbidity and/or mortality, but did not model subsequent smoking behaviour • nine studies 23,[104][105][106]128,152,157,159,167 modelled subsequent smoking behaviour and smoking-related excess morbidity and/or mortality, but did not explicitly model smoking-related morbidity • fourteen studies 108,[141][142][143][144][146][147][148][149][150]156,[162][163][164] modelled subsequent smoking behaviour and explicitly modelled one or more smoking-related morbidities, but did not include smoking-related excess morbidity or mortality • six studies 75,96,107,139,…”

Section: Model Structuresmentioning

confidence: 99%

“…Jha et al 182 reported the results of an unmatched case-control study conducted in India, which was used in one economic evaluation in this review. 155 Rogers and Powell-Griner 183 used data from two different US surveys to construct lifetables for white smokers, former smokers and non-smokers, which were used in one economic evaluation in this review. 172 Rogers et al 184 reported the results of a study using data from the US National Health Interview Survey (1990), linked to the Multiple Causes of Death database through to the end of 1997.…”

Section: Data-sharing Statementmentioning

confidence: 99%

See 1 more Smart Citation

Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT

Taylor

Thompson

Streeter

et al. 2023

Health Technol Assess

View full text Add to dashboard Cite

Background Physical activity can support smoking cessation for smokers wanting to quit, but there have been no studies on supporting smokers wanting only to reduce. More broadly, the effect of motivational support for such smokers is unclear. Objectives The objectives were to determine if motivational support to increase physical activity and reduce smoking for smokers not wanting to immediately quit helps reduce smoking and increase abstinence and physical activity, and to determine if this intervention is cost-effective. Design This was a multicentred, two-arm, parallel-group, randomised (1 : 1) controlled superiority trial with accompanying trial-based and model-based economic evaluations, and a process evaluation. Setting and participants Participants from health and other community settings in four English cities received either the intervention (n = 457) or usual support (n = 458). Intervention The intervention consisted of up to eight face-to-face or telephone behavioural support sessions to reduce smoking and increase physical activity. Main outcome measures The main outcome measures were carbon monoxide-verified 6- and 12-month floating prolonged abstinence (primary outcome), self-reported number of cigarettes smoked per day, number of quit attempts and carbon monoxide-verified abstinence at 3 and 9 months. Furthermore, self-reported (3 and 9 months) and accelerometer-recorded (3 months) physical activity data were gathered. Process items, intervention costs and cost-effectiveness were also assessed. Results The average age of the sample was 49.8 years, and participants were predominantly from areas with socioeconomic deprivation and were moderately heavy smokers. The intervention was delivered with good fidelity. Few participants achieved carbon monoxide-verified 6-month prolonged abstinence [nine (2.0%) in the intervention group and four (0.9%) in the control group; adjusted odds ratio 2.30 (95% confidence interval 0.70 to 7.56)] or 12-month prolonged abstinence [six (1.3%) in the intervention group and one (0.2%) in the control group; adjusted odds ratio 6.33 (95% confidence interval 0.76 to 53.10)]. At 3 months, the intervention participants smoked fewer cigarettes than the control participants (21.1 vs. 26.8 per day). Intervention participants were more likely to reduce cigarettes by ≥ 50% by 3 months [18.9% vs. 10.5%; adjusted odds ratio 1.98 (95% confidence interval 1.35 to 2.90] and 9 months [14.4% vs. 10.0%; adjusted odds ratio 1.52 (95% confidence interval 1.01 to 2.29)], and reported more moderate-to-vigorous physical activity at 3 months [adjusted weekly mean difference of 81.61 minutes (95% confidence interval 28.75 to 134.47 minutes)], but not at 9 months. Increased physical activity did not mediate intervention effects on smoking. The intervention positively influenced most smoking and physical activity beliefs, with some intervention effects mediating changes in smoking and physical activity outcomes. The average intervention cost was estimated to be £239.18 per person, with an overall additional cost of £173.50 (95% confidence interval −£353.82 to £513.77) when considering intervention and health-care costs. The 1.1% absolute between-group difference in carbon monoxide-verified 6-month prolonged abstinence provided a small gain in lifetime quality-adjusted life-years (0.006), and a minimal saving in lifetime health-care costs (net saving £236). Conclusions There was no evidence that behavioural support for smoking reduction and increased physical activity led to meaningful increases in prolonged abstinence among smokers with no immediate plans to quit smoking. The intervention is not cost-effective. Limitations Prolonged abstinence rates were much lower than expected, meaning that the trial was underpowered to provide confidence that the intervention doubled prolonged abstinence. Future work Further research should explore the effects of the present intervention to support smokers who want to reduce prior to quitting, and/or extend the support available for prolonged reduction and abstinence. Trial registration This trial is registered as ISRCTN47776579. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 27, No. 4. See the NIHR Journals Library website for further project information.

show abstract

Leave no one behind: Rethinking policy and practice at the national level to prevent mental disorders

Papola,

Barbui,

Patel

2024

Mental Health & Prevention

View full text Add to dashboard Cite

German EstSmoke: estimating adult smoking‐related costs and consequences of smoking cessation for Germany

Abstract: Modelling suggests that the life-time healthcare costs of people in Germany who smoke are substantially greater than those of people who have never smoked. However, more comprehensive tobacco control policies could reduce health-care expenditures for current smokers by at least 4%.

Cited by 5 publications

References 46 publications

Economic damage from smoking associated with four groups of chronic non-communicable diseases in the Russian Federation in 2016

Economic damage from smoking associated with four groups of chronic non-communicable diseases in the Russian Federation in 2016

Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT

Leave no one behind: Rethinking policy and practice at the national level to prevent mental disorders

Contact Info

Product

Resources

About